Table 3 Encounter type by number selected as “in-person” appropriate only
From: Telemedicine use by pediatric rheumatologists during the COVID-19 pandemic
| Encounter Type | Number selected in-person only | % selected in-person only |
|---|---|---|
| Follow-up due to concern for flare | 120 | 53.8% |
| New patient consultations | 107 | 47.9% |
| Triage for anticipated hospitalization | 106 | 47.5% |
| Patient concern for worsening condition | 78 | 34.9% |
| Injection teaching | 57 | 25.5% |
| Need for labs | 22 | 9.8% |
| Routine follow-up visits | 15 | 6.7% |